u/Downtown-Bowler5373

I went through every rapamycin discussion across FoundMyFitness, The Drive, and Huberman Lab. About 55 timestamped clips spanning 2016 to 2025. Every claim below links to the exact moment in the source podcast. If I got something wrong, you can verify it in 30 seconds.

Three patterns emerged that I think are worth sharing.

First, Peter Attia, Matt Kaeberlein, and David Sabatini agree on much more about rapamycin than the dose-debate framing on this forum and others suggests. They're literally in the same room (Drive Ep 272, Sept 2023), and the differences are nuance, not disagreement.

Second, there are real gaps. PEARL trial data isn't covered in depth in any of these podcasts as of my corpus. Women-specific dosing isn't really discussed despite ITP showing sex differences in mice.

Third, some commonly cited "concerns" are outdated.

Here's what's actually in the primary sources.

WHAT PETER ATTIA ACTUALLY DOES

Attia takes 8mg orally once per week, has been on it for years, and pauses when he develops aphthous ulcers (canker sores), which hits roughly 10% of users. He explicitly says he doesn't feel anything subjectively. He also notes that about 2 of his patients on rapamycin report feeling better, but he's skeptical that's not placebo.

Cost: about $5/mg, or $40/week at his dose.

His framing: rapamycin and caloric restriction are the only two interventions that have extended lifespan across yeast, worms, flies, and mammals. He categorizes it as his only true "geroprotector."

Hear it from Attia (with Huberman, July 2024): https://www.leita.io/search?domain=health&video=79p1X_7rAMo&t=1020

WHAT KAEBERLEIN'S SURVEY SHOWS

Matt Kaeberlein appears as a guest on Attia Ep 272 (Sept 2023) along with David Sabatini. His survey of off-label rapamycin users shows:

Majority dose is 6mg once weekly. Bimodal distribution with a cluster at 3mg. Some users go up to 20mg/week.

Kaeberlein is more cautious than Attia on extrapolating from mouse data. The ITP studies use chronic daily dosing at 0.1 mg/kg in mice. Translating that to human weekly pulsing is, in his words, an open question that the field hasn't resolved.

Hear Kaeberlein on the survey data: https://www.leita.io/search?domain=health&video=O67pvKxio10&t=9960

WHAT DAVID SABATINI ADDS

Sabatini discovered mTOR. His mechanistic take in the same episode: autophagy is likely the primary driver of rapamycin's longevity effect. The mTORC2 selectivity concern (rapamycin hits mTORC1 at low doses, mTORC2 at higher chronic doses) is real but not a deal-breaker for weekly pulsing protocols.

THE NOVARTIS/MANNICK STUDY EVERYONE CITES

When these three reference "human safety data," they mean Joan Mannick's everolimus trial. 5mg/week of everolimus (a rapamycin analog) in elderly patients improved vaccine response and was well tolerated. Not lifespan data, but the closest we have to a controlled human trial showing benefit at low weekly doses.

Discussion of the Mannick data in Drive Ep 272: https://www.leita.io/search?domain=health&video=O67pvKxio10&t=5760

WHERE THEY AGREE

Going through every clip systematically, the three converge on:

Weekly pulsing beats daily dosing. The 3 to 10 mg/week range is the off-label window that's emerged. Mouse-to-human dose translation is genuinely unclear. mTORC1 vs mTORC2 selectivity matters but isn't a stop sign at these doses. There is no good human biomarker for "is this working." About 10% canker sore incidence is real. Cost is a genuine barrier.

WHERE THE DATA STILL ISN'T

What I couldn't find in 55 clips, despite looking:

Anything substantial on rapamycin and women specifically. ITP showed bigger effects in male mice, which is an open question for humans. Detailed hyperlipidemia discussion (mentioned once, not unpacked). Wound healing concerns (mentioned in passing). The PEARL trial specifically, which I'd expected to find. PEARL results were published 2024 and these podcasts haven't covered them in any depth in my corpus.

OUTDATED TAKES TO IGNORE

Mark Mattson (2021) said he was hesitant to take rapamycin because of immunosuppression history. That position doesn't hold up well against the Mannick data. Low weekly doses appear to enhance immune function in older adults, not suppress it. The transplant patient framing is the wrong reference class for geroprotector dosing.

ONE THING WORTH NOTICING

Rhonda Patrick has interviewed people about rapamycin since 2016 but doesn't appear to take it herself. Her implicit position across ten years of clips is closer to preferring fasting and exercise to hit similar pathways without the immunosuppression risk, though she never frames it that explicitly. Worth flagging because "three longevity researchers all take rapamycin" isn't quite right. Attia takes it, Kaeberlein endorses but his personal use isn't clear from these sources, and Rhonda hasn't taken the leap.

WHY I'M POSTING THIS

Most "expert says X" posts about supplements are written by people who watched one clip and assumed they got the gist. The original quote is usually three sentences long, missing the qualifier that came two minutes later.

I built leita.io specifically because I kept losing track of the qualifiers. The clips above link to the exact moment in the actual podcast. The tool is free, no login. Search any concept and it returns timestamped moments from primary sources rather than AI summaries.

If anyone has primary source clips on PEARL trial coverage from podcasts I haven't indexed, I'd appreciate pointers. That's the biggest gap in this picture.

Written by a human, formatted by AI.

I've been using the sauna at my BJJ gym 3-4 times a week. The problem is that the sauna (infrared) doesn't get warm enough. I have to sit at least 40 minutes to get some sweat going. After reading and listening to experts like Rhonda Patrick and others, I've now decided to build my own sauna outside my house. This article gives a thorough overview of my findings using a search engine for podcasts.

(All links go to a podcast search engine with timestamped clips — no affiliate links, no product sales, just researchers discussing these studies)

There's a Finnish study most people haven't heard of. 2,315 middle-aged men tracked for over 20 years. The finding? Men who used the sauna 4-7 times per week had a 40% lower risk of all-cause mortality compared to those who went once a week.

Not 4%. Not 14%. Forty percent.

Dr. Jari Laukkanen (the lead researcher on the study) breaks down the dose-response curve himself: 2-3 sessions per week drops mortality risk by 24%. But bump it to 4-7 times per week and you hit that 40% reduction. The cardiovascular mortality numbers are even more dramatic, a 50% reduction for frequent users.

This isn't some small pilot study. It's one of the longest follow-up periods in sauna research, and the results held even after adjusting for physical activity, lipids, diabetes, and diet. The effect is independent of how much you exercise.

Laukkanen explaining the dose-response

The protocol matters more than you think

Here's where most people get it wrong. Sitting in a warm sauna for 45 minutes does almost nothing. The Finnish studies used a specific protocol: 174°F (around 80°C), 20 minutes per session, 10-20% humidity.

Why does temperature matter? Rhonda Patrick explains the threshold effect: at 163°F for 30 minutes, heat shock proteins increase by 50% and stay elevated for 48 hours. These proteins prevent misfolded proteins from accumulating, the same kind of protein aggregation linked to Alzheimer's and other neurodegenerative diseases.

But if you're sitting in a 140°F gym sauna wondering why you're not seeing benefits, that's why. Temperature isn't negotiable.

Duration isn't either. Laukkanen's team found that sessions under 11 minutes produced almost no effect, while 19+ minutes showed robust benefits. The sweet spot appears to be 20 minutes.

Rhonda on heat shock proteins and temperature threshold

It mimics cardio, literally

Peter Attia discussed this with Rhonda Patrick: intervention studies show that adding sauna sessions after cycling produces greater VO2 max improvements than cycling alone. Sauna isn't a replacement for exercise, but it amplifies the cardiovascular adaptations you're already getting.

The mechanisms are surprisingly similar to moderate-intensity cardio. One 30-minute session acutely lowers blood pressure and improves arterial compliance. Long-term, frequent sauna use reduces hypertension incidence and improves endothelial function.

Rhonda Patrick's more recent review confirms this synergy: people who combine regular exercise with sauna have lower all-cause mortality than those who just exercise. Cholesterol and blood pressure improvements are also greater when sauna is added to an exercise routine.

What 40% actually means

A 40% reduction in all-cause mortality sounds abstract. Here's what it looks like in practice: if 10 men out of 1,000 would normally die in a given year, frequent sauna use brings that down to 6. Over a 20-year period, that's substantial.

The cardiovascular benefits are even clearer. The same study found a 50% reduction in cardiovascular mortality and a 14% reduction in stroke risk for those using sauna 2-3 times per week. These effects held for people with type 2 diabetes, a population typically at higher risk.

And there's a dose-response relationship you can act on. Rhonda Patrick breaks it down: 10-minute sessions produce only an 8% reduction in sudden cardiac death risk. But 19+ minutes gets you to 25%. Frequency follows the same pattern, once per week is marginally beneficial, but 4+ times per week is where the robust effects show up.

Rhonda on the exact dose-response curve

The practical takeaway

If you have access to a sauna, the protocol is straightforward: 20 minutes at 174°F (80°C), 4 times per week. If your gym sauna runs cooler, you'll need to compensate with longer sessions or higher frequency, though the Finnish data specifically used high-heat traditional saunas.

Infrared saunas are popular, but almost all the longevity studies used traditional Finnish saunas. Infrared may work, but you're extrapolating beyond the data if you assume equivalent effects at lower temperatures.

Full sauna protocol breakdown and additional clips

Written by a human, formatted by AI.